Anticoagulation Forum/X
Jun 2, 2025, 08:35
Refining Thrombophilia Testing: New ACE Rapid Resource Offers Practical Guidance for Clinicians – Anticoagulation Forum
The Anticoagulation Forum has released a new ACE Rapid Resource shared on X, offering concise, evidence-based guidance on thrombophilia testing, built on the most current clinical guidelines. This resource supports clinicians across a range of scenarios—from determining the appropriateness of testing to accurately interpreting results.
“Key features include:
Indications for Testing: Defines clinical contexts where thrombophilia testing is justified, helping to prevent overuse and reduce diagnostic errors.
Interpretation Framework: Offers expert-driven explanations on how to interpret test results in the presence of confounding factors such as acute illness, medications, pregnancy, or hormonal therapy.
Clinical Application: Equips healthcare providers with actionable insights to improve diagnostic accuracy and enhance patient outcomes in suspected thrombophilia.
This resource is a collaboration led by Greg Hadlock, PharmD, PhD, with clinical input from Jean Connors, MD, and an expert panel, and is part of a growing library of high-quality tools offered by the Anticoagulation Forum.”
Access the full resource on ACE Rapid Resource – Thrombophilia Testing․
Thrombophilia Testing: Key Insights from the ACE Rapid Resource
The Anticoagulation Forum’s ACE Rapid Resource offers a streamlined, evidence-based summary to guide clinicians on when and how to perform thrombophilia testing. It emphasizes:
- Appropriate indications to avoid unnecessary testing and misinterpretation.
- Result interpretation in the context of confounding factors such as acute illness, medications, and pregnancy.
- Clinical integration to support accurate diagnosis and optimize patient outcomes.
- This resource reflects current best practices and is intended to enhance decision-making in complex thrombotic risk assessments.
Discover the latest expert insights in Hemostasis Today.
-
Dec 12, 2025, 23:51Don’t Miss: IACH Post ASH 2025 Roundtable Debate
-
Dec 12, 2025, 23:37C-Reactive Protein and Cardiovascular Risk in the General Population: A European Heart Journal Study by Berkan Kurt et al.
-
Dec 12, 2025, 23:23Alta Schutte and Colleagues at National Hypertension Taskforce: Driving Single-Pill Therapy for Hypertension and More
-
Dec 12, 2025, 22:27Normal Counts, High Risk: Abdul Mannan Breaks Down JAK2 + Splanchnic Vein Thrombosis
-
Dec 12, 2025, 14:478 Posts Not to Miss From the ASH 2025 – Marc Carrier
-
Dec 12, 2025, 10:17Alyssa George on Clinical and Economic Impact of a Eptacog Beta
-
Dec 12, 2025, 09:53Ivan Budnik Awarded AHA Postdoctoral Fellowship! Aiming to Improve DVT Long-term Outcomes
-
Dec 12, 2025, 09:34Giles Platford on Baby Big: Plasma-Derived Drug Against Infant Botulism
-
Dec 12, 2025, 09:22Matteo Foschi Presents The New Expert Guidance on Minor Ischemic Stroke
